Dr. William K. Andersen is a dermatologist in Lancaster,Pennsylvania. He graduated from Columbia University College of Physicians and Surgeons in 1987 and has been in practice for 35 years.
Columbia University College of Physicians and Surgeons, 1987
Male
1538135900
| Description | # of Times Performed | # of Patients | Average Charge ($) |
|---|---|---|---|
| Tangential biopsy of single skin lesion | 176.0 | 164.0 | 158.29545455 |
| Tangential biopsy of additional skin lesion | 15.0 | 14.0 | 83.6 |
| Punch biopsy of single skin lesion | 14.0 | 12.0 | 182.0 |
| Shaving of 0.6 centimeters to 1.0 centimeters skin growth of the trunk, arms, or legs | 16.0 | 12.0 | 196.0 |
| Removal of malignant growth (1.1 to 2.0 centimeters) of the trunk, arms, or legs | 16.0 | 16.0 | 414.0 |
| Removal of malignant growth (1.1 to 2.0 centimeters) of the scalp, neck, hands, feet, or genitals | 20.0 | 20.0 | 431.0 |
| Removal of malignant growth (0.6 to 1.0 centimeters) of the face, ears, eyelids, nose, or lips | 11.0 | 11.0 | 395.0 |
| Removal of malignant growth (1.1 to 2.0 centimeters) of the face, ears, eyelids, nose, or lips | 31.0 | 31.0 | 547.0 |
| Repair of wound (2.6 to 7.5 centimeters) of the scalp, underarms, trunk, arms, and/or legs | 54.0 | 51.0 | 504.0 |
| Repair of wound (2.6 to 7.5 centimeters) of neck, hands, feet, and/or genitals | 18.0 | 18.0 | 549.0 |
| Repair of wound (2.6 to 5.0 centimeters) of face, ears, eyelids, nose, lips, and/or mouth | 54.0 | 52.0 | 485.0 |
| Destruction of skin growth | 596.0 | 484.0 | 122.0 |
| Destruction of 2-14 skin growths | 749.0 | 257.0 | 25.0 |
| Destruction of up to 14 skin growths | 34.0 | 32.0 | 171.0 |
| Destruction of malignant growth (0.5 centimeters or less) of trunk, arms, or legs | 23.0 | 21.0 | 214.0 |
| Destruction of malignant growth (0.6 to 1.0 centimeters) of trunk, arms, or legs | 105.0 | 83.0 | 237.0 |
| Destruction of malignant growth (1.1 to 2.0 centimeters) of trunk, arms, or legs | 41.0 | 37.0 | 334.2195122 |
| Destruction of malignant growth (0.5 centimeters) of scalp, neck, hands, feet, or genitals | 15.0 | 15.0 | 249.0 |
| Destruction of malignant growth (0.6 to 1.0 centimeters) of scalp, neck, hands, feet, or genitals | 30.0 | 25.0 | 273.0 |
| Destruction of malignant growth (1.1 to 2.0 centimeters) of scalp, neck, hands, feet, or genitals | 11.0 | 11.0 | 339.54545455 |
| Destruction of malignant growth (0.5 centimeters or less) of face, ears, eyelids, nose, lips, or mouth | 30.0 | 26.0 | 268.0 |
| Destruction of malignant growth (0.6 to 1.0 centimeters) of face, ears, eyelids, nose, lips, or mouth | 40.0 | 35.0 | 364.0 |
| Removal and microscopic examination of growth of the head, neck, hands, feet, or genitals (first stage, up to 5 tissue blocks) | 92.0 | 88.0 | 1074.0 |
| Removal and microscopic examination of growth of the head, neck, hands, feet, or genitals | 49.0 | 46.0 | 647.0 |
| Tissue fungi or parasites | 18.0 | 18.0 | 32.0 |
| Pathology examination of tissue using a microscope, moderately low complexity | 32.0 | 28.0 | 105.0 |
| Pathology examination of tissue using a microscope, intermediate complexity | 1082.0 | 716.0 | 171.0 |
| Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | 17.0 | 11.0 | 60.0 |
| Application of light and light-sensitive drugs to aid destruction of premalignant skin growths, per session | 45.0 | 43.0 | 323.0 |
| New patient office or other outpatient visit, typically 20 minutes | 57.0 | 57.0 | 122.0 |
| New patient office or other outpatient visit, typically 30 minutes | 61.0 | 61.0 | 183.0 |
| Established patient office or other outpatient visit, typically 5 minutes | 22.0 | 21.0 | 67.0 |
| Established patient office or other outpatient visit, typically 10 minutes | 76.0 | 66.0 | 89.881578947 |
| Established patient office or other outpatient visit, typically 15 minutes | 968.0 | 754.0 | 129.38533058 |
| Established patient office or other outpatient, visit typically 25 minutes | 725.0 | 653.0 | 175.0 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 64.0 | 17.0 | 25.0 |
| Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | 45.0 | 43.0 | 550.0 |
Cookies on this website are used to improve your experience and display advertising. You agree to the use of cookies by continuing to use this website. Our Privacy Policy contains more information about how we use cookies.